Probing the mechanism of reduced in vivo potency of insulin detemir

Taylor and Francis Group, Expert Opinion on Drug Metabolism and Toxicology, 4(19), p. 225-228, 2023

Journal article published in 2023 by Christian Lehn Brand

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by